The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Open accessAbstract
BACKGROUND: The use of proton pump inhibitors has been associated with an increased risk of hip fracture. We sought to further explore the relation between duration of exposure to proton pump inhibitors and osteoporosis-related fractures. METHODS: We used administrative claims data to identify patients with a fracture of the hip, vertebra or wrist between April 1996 and March 2004. Cases were each matched with 3 controls based on age, sex and comorbidities. We calculated adjusted odds ratios (OR) for the risk of hip fracture and all osteoporosis-related fractures for durations of proton pump inhibitor exposure ranging from 1 or more years to more than 7 years. RESULTS: We matched 15 792 cases of osteoporosis-related fractures with 47 289 controls. We did not detect a significant association between the overall risk of an osteoportic fracture and the use of proton pump inhibitors for durations of 6 years or less. However, exposure of 7 or more years was associated with increased risk of an osteoporosis-related fracture (adjusted OR 1.92, 95% confidence interval [CI] 1.16-3.18, p = 0.011). We also found an increased risk of hip fracture after 5 or more years of exposure (adjusted OR 1.62, 95% CI 1.02-2.58, p = 0.04), with even higher risk after 7 or more years exposure (adjusted OR 4.55, 95% CI 1.68-12.29, p = 0.002). INTERPRETATION: Use of proton pump inhibitors for 7 or more years is associated with a significantly increased risk of an osteoporosis-related fracture. There is an increased risk of hip fracture after 5 or more years exposure. Further study is required to determine the clinical importance of this finding and to determine the value of osteoprotective medications for patients with long-term use of proton pump inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Calcium supplementation on bone loss in postmenopausal women
Shea, B., Adachi, J., Cranney, A., Griffith, L. E., Guyatt, G. H., Hamel, C., Ortiz, Z., Peterson, J., Robinson, V., Tugwell, P., et al. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004526.pub2 · Cited by 137
RetractedAn estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Kanis, J. A., Borgstrom, F., De Laet, C., Johansson, H., Johnell, O., Jonsson, B., Oden, A., Zethraeus, N., Pfleger, B., & Khaltaev, N. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1780-5 · Cited by 1,233
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
Torgerson, D. J., & Bell-Syer, S. E. M. (2001) · JAMA · doi:10.1001/jama.285.22.2891 · Cited by 522
TYPE OF FALL AND RISK OF HIP AND WRIST FRACTURES: THE STUDY OF OSTEOPOROTIC FRACTURES
Drinka, P. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06547.x · Cited by 475
Hannan, E. L., Magaziner, J., Wang, J. J., Eastwood, E. A., Silberzweig, S. B., Gilbert, M., Morrison, R. S., McLaughlin, M. A., Orosz, G. M., & Siu, A. L. (2001) · JAMA · doi:10.1001/jama.285.21.2736 · Cited by 455
TYPE OF FALL AND RISK OF HIP AND WRIST FRACTURES: THE STUDY OF OSTEOPOROTIC FRACTURES
Nevitt, M. C., & Cummings, S. R. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06576.x · Cited by 403
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
Richards, J. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.188 · Cited by 386
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Physical Activity and Osteoporotic Fracture Risk in Older Women
Gregg, E. W., Cauley, J. A., Seeley, D. G., Ensrud, K. E., & Bauer, D. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00002 · Cited by 369
Tenenhouse, A., Joseph, L., Kreiger, N., Poliquin, S., Murray, T. M., Blondeau, L., Berger, C., Hanley, D. A., & Prior, J. C. (2000) · Osteoporosis International · doi:10.1007/s001980070050 · Cited by 302
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Haney, E. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1246 · Cited by 286
Gastrointestinal Absorption of Calcium from Milk and Calcium Salts
Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., Schiller, L. R., & Fordtran, J. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708273170903 · Cited by 260
Adachi, J. D., Ioannidis, G., Berger, C., Joseph, L., Papaioannou, A., Pickard, L., Papadimitropoulos, E. A., Hopman, W., Poliquin, S., Prior, J. C., et al. (2001) · Osteoporosis International · doi:10.1007/s001980170017 · Cited by 258
Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238
Current and projected rates of hip fracture in Canada.
Papadimitropoulos, E., Coyte, P. C., Josse, R. G., & Greenwood, C. E. (1997) · Europe PMC (PubMed Central) · Cited by 217
An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.
Bo-Linn, G. W., Davis, G. R., Buddrus, D. J., Morawski, S. G., Santa Ana, C., & Fordtran, J. S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111254 · Cited by 217
Step-down management of gastroesophageal reflux disease
Inadomi, J. M., Jamal, R., Murata, G. H., Hoffman, R. M., Lavezo, L. A., Vigil, J. M., Swanson, K. M., & Sonnenberg, A. (2001) · Gastroenterology · doi:10.1053/gast.2001.28649 · Cited by 192
Weight Change and Fractures in Older Women
Ensrud, K. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440290041004 · Cited by 186
BJÖRNSSON, E., ABRAHAMSSON, H., SIMRÉN, M., MATTSSON, N., JENSEN, C., AGERFORZ, P., & KILANDER, A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03084.x · Cited by 186
Use of Oral Corticosteroids and Risk of Fractures
van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.8.1486 · Cited by 171
Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group
Ensrud, K. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.8.857 · Cited by 144
Who is using chronic acid suppression therapy and why?
Jacobson, B. C., Ferris, T. G. G., Shea, T. L., Mahlis, E. M., Lee, T. H.-Y., & Wang, T. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07186.x · Cited by 143
Effectiveness of Bone Density Measurement for Predicting Osteoporotic Fractures in Clinical Practice
Leslie, W. D., Tsang, J. F., Caetano, P. A., Lix, L. M., & Program, F. T. M. B. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1415 · Cited by 143
Self-citationAlcohol Intake and Its Relationship with Bone Mineral Density, Falls, and Fracture Risk in Older Men
Cawthon, P. M., Harrison, S. L., Barrett-Connor, E. L., Fink, H. A., Cauley, J. A., Lewis, C. E., ORWOLL, E. S., & Cummings, S. R. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00912.x · Cited by 124
Sun, S. X., Lee, K. Y., Bertram, C. T., & Goldstein, J. L. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210561 · Cited by 110
Wilcox, C. M., Allison, J. J., Benzuly, K. H., Borum, M. L., Cryer, B., Großer, T., Hunt, R. H., Ladabaum, U., Lanas, Á., Paulus, H. E., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.010 · Cited by 98
Longterm Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Barkin, J. S. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70245-1 · Cited by 61
Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney, A., Adachi, J., Guyatt, G. H., Παπαϊωάννου, Α., Robinson, V., Shea, B., Tugwell, P., Waldegger, L., Weaver, B., Wells, G. A., et al. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004523 · Cited by 58
Establishing a Population Data-Based Policy Unit
Roos, N. P. (1999) · Medical Care · doi:10.1097/00005650-199906001-00006 · Cited by 41
Leslie, W. D., Anderson, W. A., Metge, C. J., & Manness, L.-J. (2006) · Bone · doi:10.1016/j.bone.2006.11.008 · Cited by 24
Self-citationRisedronate for the prevention and treatment of postmenopausal osteoporosis
Cranney, A., Adachi, J., Guyatt, G. H., Παπαϊωάννου, Α., Robinson, V., Shea, B., Tugwell, P., Waldegger, L., Weaver, B., Wells, G. A., et al. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004523.pub2 · Cited by 22
Torgerson, D. J., & Bell-Syer, S. E. M. (2001) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 18
Cited by
Barkun, A. N., Bardou, M., Kuipers, E. J., Sung, J., Hunt, R. H., Martel, M., Sinclair, P., & for the International Consensus Upper Gastrointestinal Bleeding Conference Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00009 · Cited by 1,163
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001538 · Cited by 1,038
Moayyedi, P., Eikelboom, J. W., Bosch, J., Connolly, S. J., Dyal, L., Shestakovska, O., Leong, D., Anand, S. S., Störk, S., Branch, K. R. H., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.056 · Cited by 483
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Metadata
- Authors
- Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2008-08-12
- Volume
- 179
- Issue
- 4
- Pages
- 319-326
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2143121646
- Cited by
- 436
- References
- 39
- FWCI
- 39.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.